Found 6 matching trials
A Study of the Abuse Liability Potential of Samidorphan in Healthy, Non-Dependent, Recreational Opioid Users
PHASE1The purpose of this study is to evaluate the abuse potential and safety of ...
Location
Alkermes Investigational Site
ALK33-101: A Study of RDC-0313 (ALKS 33) in Adults With Binge Eating Disorder
PHASE2The purpose of this study is to evaluate the safety of daily doses of RDC-0...
Location
Alkermes' Investigational Study Site
A Study of ALKS 3831 in Adults With Schizophrenia
PHASE2This is a Phase 2, randomized, placebo-controlled multicenter study, which ...
Location
Alkermes Investigational Site
ALK33BUP-201: Safety and Tolerability Study of ALKS 33-BUP (ALKS 5461) Administration in Subjects With MDD
PHASE1This is a multicenter, randomized, double-blind, placebo-controlled, parall...
Location
Comprehensive NeuroScience, Inc.
ALK33BUP-101: Safety and Pharmacodynamic Effects of ALKS 33-BUP Administered Alone and When Co-administered With Cocaine
PHASE1The purpose of this study is to assess the safety and tolerability of ALKS3...
Location
Alkermes Study Site
A Study of [14c]-Samidorphan (Also Known as ALKS 33) in Healthy, Male Volunteers
PHASE1This study will determine the pharmacokinetics (PK) of \[14c\]-samidorphan ...
Location
Alkermes Investigational Site